<DOC>
	<DOCNO>NCT02739698</DOCNO>
	<brief_summary>A randomize control single-blind clinical trial perform , 32 patient diagnosed peritoneal carcinomatosis epithelial ovarian cancer , underwent radical surgery-peritonectomy , achieve optimal R0-R1 cytoreduction ( microscopic tumor residue ( R0 ) macroscopic tumor residue &lt; 1cm ( R1 ) ) follow hyperthermia normothermia intraperitoneal intraoperative chemotherapy paclitaxel</brief_summary>
	<brief_title>Role Intraperitoneal Intraoperative Chemotherapy With Paclitaxel Surgical Treatment Peritoneal Carcinomatosis From Ovarian Cancer . Hyperthermia Versus Normothermia</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1. age range 18 75 year old ; 2. histopathologic confirmation peritoneal carcinomatosis epithelial ovarian cancer ( stage IIIc FIGO ( International Federation Gynecology Obstetrics ) ) ; 3 . Karnofsky index &gt; 70 performance status â‰¤2 ; 4. informed consent form fill correctly . 1. unfulfillment inclusion criterion ; 2. extraabdominal metastasis stage IV FIGO ( liver , lung , bone , etc ) ; 3. concomitance another malignant neoplasm ; 4. renal , hepatic cardiovascular dysfunction ; 5. intolerance treatment ; ( 6 ) refusal participate study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ovarian cancer</keyword>
</DOC>